Navigation Links
Amnis and Gene Company, Ltd. Announce Agreement to Market ImageStream Technology in China
Date:5/7/2008

SEATTLE, May 7 /PRNewswire/ -- Amnis Corporation and Gene Company, Ltd. announced today the completion of an agreement under which Gene Company will sell and service the Amnis ImageStream(R) system in China. Effective immediately, the scientific research communities in Hong Kong, Shanghai, Beijing and Guangzhou now have access to this important cell analysis technology.

"We are extremely pleased to have begun what we expect will be a valuable partnership with Gene Company. We are looking forward to working with them to expand the commercial presence of the ImageStream in China," said David Basiji, Ph.D., Amnis' President and CEO. "Gene Company has a strong presence in the major Chinese scientific markets and brings a distinguished history as a supplier to the partnership. We are quite confident that they will represent the ImageStream extremely well."

Dr. Cheung To, Chairman of Gene Company, added, "We envisage that distribution of the Amnis ImageStream system will remarkably empower pioneering labs with next generation microscopy and flow cytometry in a single platform to advance applications in drug discovery, molecular and cellular research and diagnostics in China. Gene Company has high confidence in Amnis and looks forward to a synergetic cooperation."

About Amnis:

Amnis Corporation, headquartered in Seattle, WA, develops, manufactures and markets the ImageStream system for high speed imaging of cells in flow. The system generates six high resolution microscopic images of cells as they flow through the instrument at rates up to 300 cells per second. The system is unique in its ability to image tens of thousands of cells in minutes without the need to make slides. The IDEAS(R) image analysis package, an integral part of the ImageStream system, is a highly sophisticated yet easy to use tool for processing hundreds of thousands of images at a time. IDEAS enables highly advanced research applications in hematology, immunology, oncology and provides a critical foundation for the company's clinical applications development.

About Gene Company:

Gene Company Limited (Gene Company) incorporated in 1992 and headquartered in Hong Kong, has established presences in 20 major cities in P.R. China. Over the years of development, Gene Company is regarded as one of the largest distribution network in China and established a solid and highly loyal customer base, constituting renowned research institutes, hospitals, and pharmaceutical and biotech companies. Gene Company has also successfully become one of the major research product suppliers to key genomics, proteomics, biochip and stem cell research centres. More information about Gene Company is obtainable from their home page: http://www.genehk.com.


'/>"/>
SOURCE Amnis Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System
2. Amnis Announces Release of Powerful New Image Data Analysis Software
3. The Jordan Company, L.P. Has Teamed with the Management of Haas TCM Inc. to Form Haas TCM Group Inc.
4. China Aoxing Pharmaceutical Company Signed Definitive Acquisition Agreement to Acquire Shijiazhuang Lerentang Pharmaceutical Company, Ltd.
5. InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions
6. Pathology Consultants, Inc. Selects PSA, LLC, a MED3OOO Company, as Their Business Partner
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... A new study published ... frozen and fresh in vitro fertilization (IVF) transfer cycles. The multi-center ... success. , After comparing the results from the fresh and frozen transfer cohorts, ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... firm Parks Associates announced today that Tom Kerber , ... Meeting , October 11 in Scottsdale, Arizona . Kerber ... smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... recipients of 13 prestigious awards honoring scientists who have made ... in a scheduled symposium during Pittcon 2018, the world’s leading conference and exposition ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
Breaking Biology News(10 mins):